Roth Mkm Increases CervoMed (NASDAQ:CRVO) Price Target to $15.00
CervoMed (NASDAQ:CRVO – Get Free Report) had its price objective raised by analysts at Roth Mkm from $7.00 to $15.00 in a research note issued on Tuesday,Benzinga reports. The firm presently has a “buy” rating on the stock. Roth Mkm’s price objective indicates a potential upside of 143.11% from the company’s current price. CRVO has […]
CervoMed (NASDAQ:CRVO – Get Free Report) had its price objective raised by analysts at Roth Mkm from $7.00 to $15.00 in a research note issued on Tuesday,Benzinga reports. The firm presently has a “buy” rating on the stock. Roth Mkm’s price objective indicates a potential upside of 143.11% from the company’s current price. CRVO has […]
